Bjork Elisabeth
SEC CIK 1810406 · EDGAR
BoughtSold
Most active insiders at PHVS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schikan Johannes Gerardus Christiaan Petrus | Dir | — | $9.65M |
| 2 | Lu Peng | Pres | — | $6.95M |
| 3 | Lesage Anne | Chief Early Development | — | $6.67M |
| 4 | Bjork Elisabeth | Dir | — | $2.28M |
| 5 | Abele Stefan Andreas | Chief Technical Ops Off | — | $2.03M |
| 6 | Glassman Robert | Dir | — | $1.49M |
| 7 | Souverijns Wim | Chief Commercial Off | — | $1.32M |
| 8 | Modig Berndt | CEO, Dir | — | $1.10M |
| 9 | Nassif David W. | CFO, CLO | — | $521.9K |
| 10 | Nijdam Anna | Principal Accounting Off | — | $307.5K |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-09-21 15:20 | 2026-09-17 | PHVS | Pharvaris N.V. | Bjork Elisabeth | Dir | M - OptEx | $15.64 | +52.5K | 67.7K | +346% | +$821.1K |
| D | 2026-09-21 15:20 | 2026-09-17 | PHVS | Pharvaris N.V. | Bjork Elisabeth | Dir | S - Sale+OE | $37.89 | -52.5K | 15.2K | -78% | -$1.99M |
| DT | 2026-05-22 14:54 | 2026-05-20 | PHVS | Pharvaris N.V. | Bjork Elisabeth | Dir | M - OptEx | $8.05 | +10.0K | 25.2K | +66% | +$80.5K |
| DT | 2026-05-22 14:54 | 2026-05-20 | PHVS | Pharvaris N.V. | Bjork Elisabeth | Dir | S - Sale+OE | $29.32 | -10.0K | 15.2K | -40% | -$293.2K |
| 2026-01-06 | 2026-01-02 | RCKT | ROCKET PHARMACEUTICALS, INC. | Bjork Elisabeth | Dir | P - Purchase | $3.44 | +10.0K | 50.0K | +25% | +$34.4K | |
| 2025-08-27 | 2025-08-27 | RCKT | ROCKET PHARMACEUTICALS, INC. | Bjork Elisabeth | Dir | P - Purchase | $3.41 | +10.0K | 40.0K | +33% | +$34.1K | |
| 2025-07-18 | 2025-06-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | Bjork Elisabeth | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations